CVE:MPH

Medicure (MPH) Stock Price, News & Analysis

C$1.07
+0.07 (+7.00%)
(As of 04/29/2024)
Today's Range
C$1.07
C$1.07
50-Day Range
C$0.99
C$1.20
52-Week Range
C$0.99
C$1.80
Volume
3,000 shs
Average Volume
4,451 shs
Market Capitalization
C$10.97 million
P/E Ratio
11.89
Dividend Yield
2.24%
Price Target
N/A
MPH stock logo

About Medicure Stock (CVE:MPH)

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

MPH Stock Price History

MPH Stock News Headlines

The Gold Grab of the Century
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
The Gold Grab of the Century
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
Charing - Weather warnings issued
Portishead - Weather warnings issued
Chelmsford - Weather warnings issued
Redruth - Weather warnings issued
Leven - Weather warnings issued
See More Headlines
Receive MPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/08/2024
Today
5/04/2024
Next Earnings (Estimated)
5/24/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$1.08 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$22.94 million
Cash Flow
C$0.43 per share
Book Value
C$2.10 per share

Miscellaneous

Free Float
N/A
Market Cap
C$10.97 million
Optionable
Not Optionable
Beta
1.01
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Dr. Neil Owens Ph.D.
    President & COO
  • Dr. Reuben Saba Ph.D.
    Vice President of Scientific & Medical Affairs
  • Dr. Albert David Friesen Ph.D. (Age 77)
    Founder, CEO & Chairman of the board
    Comp: $237.6k
  • Mr. Haaris Uddin B.Com.
    CPA, Chief Financial Officer

MPH Stock Analysis - Frequently Asked Questions

How have MPH shares performed in 2024?

Medicure's stock was trading at C$1.40 at the beginning of the year. Since then, MPH stock has decreased by 23.6% and is now trading at C$1.07.
View the best growth stocks for 2024 here
.

When is Medicure's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 24th 2024.
View our MPH earnings forecast
.

How were Medicure's earnings last quarter?

Medicure Inc. (CVE:MPH) released its earnings results on Monday, April, 8th. The company reported ($0.14) earnings per share for the quarter. The business earned $5.07 million during the quarter. Medicure had a trailing twelve-month return on equity of 5.04% and a net margin of 4.71%.

What other stocks do shareholders of Medicure own?
How do I buy shares of Medicure?

Shares of MPH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:MPH) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners